1. He FJ, Li JF, MacGregor GA. Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials. BMJ. 2013;346:fl325. doi: 10.1136/bmj.f1325.
2. Vollmer WM, Sacks FM, Ard J, Appel LJ, Bray GA, Simons-Aaorton DG, et al. Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial. Ann Intern Med. 2001;135(12):1019-28. doi: 10.7326/0003-4819-135-12-200112180-00005.
3. Strazzullo P, D'Elia L, Kandala NB, Cappuccio FP. Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies. BMJ. 2009;339:b4567. doi: 10.1136/bmj.b4567.
4. He FJ, MacGregor GA. Salt reduction lowers cardiovascular risk: meta-analysis of outcome trials. Lancet. 2011;378(9789):380-2. doi: 10.1016/s0140-6736(11)61174-4.
5. Garofalo C, Borrelli S, Provenzano M, De Stefano T, Vita C, Chiodini P, et al. Dietary salt restriction in chronic kidney disease: A meta-analysis of randomized clinical trials. Nutrients. 2018;10(6):732. doi: 10.3390/nu10060732.
6. WHO. Guideline: sodium intake for adults and children. Geneva, World Health Organization (WHO), 2012.
7. Powles J, Fahimi S, Micha R, Khatibzadeh S, Shi P, Ezzati M, et al. Global, regional and national sodium intakes in 1990 and 2010: a systematic analysis of 24 h urinary sodium excretion and dietary surveys worldwide. BMJ Open. 2013;3(12):e003733. doi: 10.1136/bmjopen-2013-003733.
8. Bray GA, Popkin BM. Dietary fat intake does affect obesity! Am J Clin Nutr. 1998;68(6):1157-73. doi: 10.1093/ajcn/68.6.1157.
9. Rubin RJ, Altman WM, Mendelson DN. Health care expenditures for people with diabetes mellitus, 1992. J Clin Endocrinol Metab. 1994;78(4):809A-F. doi: 10.1210/jcem.78.4.8157701.
10. Williams R, Van Gaal L, Lucioni C; CODE-2 Advisory Board. Assessing the impact of complications on the costs of Type II diabetes. Diabetologia. 2002;45(7):S13-S7. doi: 10.1007/s00125-002-0859-9.
11. Samuel VT, Shulman GI. Mechanisms for insulin resistance: common threads and missing links. Cell. 2012;148(5):852-71. doi: 10.1016/j.cell.2012.02.017.
12. Ogihara T, Asano T, Ando K, Chiba Y, Sekine N, Sakoda H, et al. Insulin resistance with enhanced insulin signaling in high-salt diet-fed rats. Diabetes. 2001;50(3):573-83. doi: 10.2337/diabetes.50.3.573.
13. Prada P, Okamoto MM, Furukawa LN, Machado UF, Heimann JC, Dolnikoff MS. High- or low-salt diet from weaning to adulthood: effect on insulin sensitivity in Wistar rats. Hypertension. 2000;35(1 Pt 2):424-9. doi: 10.1161/01.hyp.35.1.424.
14. Fonseca-Alaniz MH, Takada J, Andreotti S, de Campos TBF, Campana AB, Borges-Silva CN, et al. High sodium intake enhances insulin-stimulated glucose uptake in rat epididymal adipose tissue. Obesity. 2008;16(6):1186-92. doi: 10.1038/oby.2008.69.
15. Lasheen NN. Pancreatic functions in high salt fed female rats. Physiol Rep. 2015;3(7):e12443. doi: 10.14814/phy2.12443.
16. Sutherland TM, Biondini PE, Ward GM. Selection for growth rate, feed efficiency and body composition in mice. Genetics. 1974;78(1):525-40.
17. Banno R, Zimmer D, De Jonghe BC, Atienza M, Rak K, Yang W, et al. PTP1B and SHP2 in POMC neurons reciprocally regulate energy balance in mice. J Clin Invest. 2010;120(3):720-34. doi: 10.1172/JCI39620.
18. Kikawa K, Sakano D, Shiraki N, Tsuyama T, Kume K, Endo F, et al. Beneficial effect of insulin treatment on islet transplantation outcomes in Akita mice. PLoS One. 2014;9(4):e95451. doi: 10.1371/journal.pone.0095451.
19. Ito Y, Banno R, Shibata M, Adachi K, Hagimoto S, Hagiwara D, et al. GABA type B receptor signaling in proopiomelanocortin neurons protects against obesity, insulin resistance, and hypothalamic inflammation in male mice on a high-fat diet. J Neurosci. 2013;33(43):17166-73. doi: 10.1523/JNEUROSCI.0897-13.2013.
20. Weidemann BJ, Voong S, Morales-Santiago FI, Kahn MZ, Ni J, Littlejohn NK, et al. Dietary sodium suppresses digestive efficiency via the renin-angiotensin system. Sci Rep. 2015;5:11123. doi: 10.1038/srep11123.
21. DeClercq VC, Goldsby JS, McMurray DN, Chapkin RS. Distinct adipose depots from mice differentially respond to a high-fat, high-salt diet. J Nutr. 2016;146(6):1189-96. doi: 10.3945/jn.115.227496.
22. Rachek LI. Free fatty acids and skeletal muscle insulin resistance. Prog Mol Biol Transl Sci. 2014;121:267-92. doi: 10.1016/B978-0-12-800101-1.00008-9.
23. Fabbrini E, Magkos F, Mohammed BS, Pietka T, Abumrad NA, Patterson BW, et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci U S A. 2009;106(36):15430-5. doi: 10.1073/pnas.0904944106.
24. Min HK, Kapoor A, Fuchs M, Mirshahi F, Zhou H, Maher J, et al. Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease. Cell Metab. 2012;15(5):665-74. doi: 10.1016/j.cmet.2012.04.004.
25. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;112(12):1821-30. doi: 10.1172/JCI19451.
26. Tajima K, Shirakawa J, Okuyama T, Kyohara M, Yamazaki S, Togashi Y, et al. Effects of metformin on compensatory pancreatic β-cell hyperplasia in mice fed a high-fat diet. Am J Physiol Endocrinol Metab. 2017;313(3):E367-E80. doi: 10.1152/ajpendo.00447.2016.
27. Stamateris RE, Sharma RB, Hollern DA, Alonso LC. Adaptive beta-cell proliferation increases early in high-fat feeding in mice, concurrent with metabolic changes, with induction of islet cyclin D2 expression. Am J Physiol-Endocrinol Metab. 2013;305(1):E149-E59. doi: 10.1152/ajpendo.00040.2013.
28. Puigserver P, Rhee J, Donovan J, Walkey CJ, Yoon JC, Oriente F, et al. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature. 2003;423(6939):550-5. doi: 10.1038/nature01667.
29. Mosser RE, Maulis MF, Moullé VS, Dunn JC, Carboneau BA, Arasi K, et al. High-fat diet-induced β-cell proliferation occurs prior to insulin resistance in C57Bl/6J male mice. Am J Physiol Endocrinol Metab. 2015;308(7):E573-82. doi: 10.1152/ajpendo.00460.2014.
30. Sánchez I, Dynlacht BD. New insights into cyclins, CDKs, and cell cycle control. Semin Cell Dev Biol. 2005;16(3):311-21. doi: 10.1016/j.semcdb.2005.02.007.
31. Kitao N, Nakamura A, Miyoshi H, Nomoto H, Takahashi K, Omori K, et al. The role of glucokinase and insulin receptor substrate-2 in the proliferation of pancreatic beta cells induced by short-term high-fat diet feeding in mice. Metab Clin Exp. 2018;85:48-58. doi: 10.1016/j.metabol.2018.03.010.
32. Zhang XB, Gaspard JP, Mizukami Y, Li JN, Graeme-Cook F, Chung DC. Overexpression of cyclin D1 in pancreatic beta-cells in vivo results in islet hyperplasia without hypoglycemia. Diabetes. 2005;54(3):712-9. doi: 10.2337/diabetes.54.3.712.
33. Arimochi H, Morita K. High salt culture conditions suppress proliferation of rat C6 glioma cell by arresting cell-cycle progression at S-phase. J Mol Neurosci. 2005;27(3):293-301. doi: 10.1385/JMN:27:3:293.
34. Kulkarni RN. New insights into the roles of insulin/IGF-I in the development and maintenance of beta-cell mass. Rev Endocr Metab Disord. 2005;6(3):199-210. doi: 10.1007/s11154-005-3051-y.
35. Tuttle RL, Gill NS, Pugh W, Lee JP, Koeberlein B, Furth EE, et al. Regulation of pancreatic beta-cell growth and survival by the serine/threonine protein kinase Akt1/PKBalpha. Nat Med. 2001;7(10):1133-7. doi: 10.1038/nm1001-1133.
36. Okada T, Liew CW, Hu J, Hinault C, Michael MD, Krutzfeldt J, et al. Insulin receptors in beta-cells are critical for islet compensatory growth response to insulin resistance. Proc Natl Acad Sci USA. 2007;104(21):8977-82. doi: 10.1073/pnas.0608703104.